The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro
- 1 May 1989
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 19 (5) , 943-946
- https://doi.org/10.1002/eji.1830190524
Abstract
To gain further insight into the mechanism of action of the immunosuppressant cyclosporin A (CyA), we investigated the influence of CyA on proliferative responses of human T lymphocytes, induced via different membrane molecules. As was previously shown, activation of T cells via the T cell receptor (Ti)/CD3 complex with an anti-CD3 monoclonal antibody was inhibited by CyA. Likewise, triggering of T lymphocytes via the alternative, CD2(T11)-mediated pathway of activation was strongly inhibited. In contrast, responses induced by phorbol myristate 13-acetate (PMA; 100 ng/ml) or the combination of an anti-CD28 monoclonal antibody and a suboptimal concentration of PMA (1 ng/ml) were found to be insensitive to CyA. CyA-induced inhibition of both anti-CD3 and anti-CD2-mediated proliferation could not be reversed by addition of either PMA (1 ng/ml) or anti-CD28. An increase in the intracellular free Ca2+ concentration ([Ca2+]i) is an early event observed after stimulation of T cells via CD3 or CD2, whereas stimulation with PMA and anti-CD28 does not lead to a rise in [Ca2+]i This suggests that the inhibitory action of CyA is related to Ca2+-dependent signaling pathways. Since we observed that CyA does not interfere with anti-CD3- or anti-CD2-induced increases of [Ca2+]i, our data suggest that CyA-mediated inhibition is related to a later event in these intracellular signaling pathways.This publication has 38 references indexed in Scilit:
- Prednisolone and cyclosporin a exert differential inhibitory effects on T-cell proliferation in vitroClinical Immunology and Immunopathology, 1988
- Signal transduction and intracellular events in T-lymphocyte activationImmunology Today, 1986
- Lymphokine and nonlymphokine mRNA levels in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A.The Journal of Experimental Medicine, 1986
- PROTEIN KINASE ACTIVATION AND THE IMMUNOSUPPESSANT CYCLOSPORINETransplantation, 1986
- Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen-receptor complex.The Journal of Experimental Medicine, 1985
- Sequential expression of genes involved in human T lymphocyte growth and differentiation.The Journal of Experimental Medicine, 1985
- Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).The Journal of Experimental Medicine, 1985
- CYCLOSPORINE DOES NOT PREVENT CYTOPLASMIC CALCIUM CHANGES ASSOCIATED WITH LYMPHOCYTE ACTIVATIONTransplantation, 1984
- An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor proteinCell, 1984
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981